Quipt Home Medical Completes Acquisition, Delists from NASDAQ and TSX

summarizeSummary

Quipt Home Medical Corp. has completed its acquisition by affiliates of Kingswood Capital and Forager for US$3.65 per share, leading to its delisting from public exchanges.

check_boxKey Events

• Acquisition Finalized

  Quipt Home Medical Corp. was acquired by affiliates of Kingswood Capital and Forager for US$3.65 per share in cash, totaling approximately $173 million. This follows shareholder approval on March 3, 2026, and court approval on March 6, 2026.

• Delisting Initiated

  The company's shares will be delisted from NASDAQ and TSX, and it will cease to be a public reporting issuer, fundamentally altering the investment thesis for public shareholders.

• Board and Management Changes

  Several directors resigned, new directors were appointed, and key officers (CFO, CAO) resigned and were reappointed, with a new Executive Chairman named following the change of control.

auto_awesomeAnalysis

This 8-K filing confirms the definitive closing of the previously announced all-cash acquisition of Quipt Home Medical Corp. by affiliates of Kingswood Capital and Forager. The transaction, valued at approximately $173 million, provides shareholders with a cash payout of US$3.65 per share, which is near the company's 52-week high. The completion of this acquisition means Quipt will cease to be a publicly traded entity, with its shares delisted from NASDAQ and TSX, and the company terminating its public reporting obligations. This marks a fundamental change for investors, concluding their public market investment in Quipt.